Trump Signals No Rush on Iran Deal Maintains Naval Blockade as Critics Face Scrutiny
European Shares Flat as US Strikes on Iran Raise Geopolitical Uncertainty
French Open Prize Money Dispute Top Players Curtail Media Duties in Protest
RBN Energy Joins Novi Labs in Strategic Energy Analytics Merger
Inside SpaceXs IPO Goldman Sachs and Morgan Stanley Lead Wall Streets Role in Potential RecordBreaking Listing
Trumps Corruption and Cynicism A Governance Risk for Markets
RCON Q4 2025 Earnings EPS Surprise Beats Estimates Amid Revenue Uncertainty
GPI Q1 2026 Earnings EPS Falls Short of Estimates Despite Positive Stock Movement
Pathward Financial CASH Q1 2026 Earnings Earnings Miss on Weaker Net Interest Income Stock Edges Up
HASI Q1 2026 Earnings EPS Beats Estimates by Double Digits Amid Steady Operational Performance
ALAB Q1 2026 Earnings EPS Beat Drives Positive Stock Movement
Gerdau SA GGB Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly
Neuberger Real Estate Securities Income Fund NRO Slips Amidst Modest Trading Activity
Senti Biosciences SNTI Holds Above Support Edges Higher Toward Key 106 Resistance
Sensei Biotherapeutics Inc SNSE Edges Higher Key Levels and Volume Analysis After a Modest Uptick
CHACU Plunges Over 10 as Crane Harbor Acquisition Corp Units Test Key Support
Dolphin Entertainment DLPN Holds Near Support After Modest Decline
Beyond Inc to Acquire Buy Buy Baby Brand Rights Reunite with Bed Bath Beyond
EBMT Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher
Flex Ltd FLEX Edges Higher Consolidation Near Key Resistance
Prudential Financial PRU Slides Slightly Amid Sector Headwinds Key Levels to Watch
TG Therapeutics TGTX Slips Modestly as Stock Consolidates Near Key Support Levels
Via Transportation Inc VIA Edges Higher Amid Consolidation Key Levels to Watch
JE Cleantech Holdings JCSE Edges Higher Testing Key Resistance Level
BrandywineGLOBAL Global Income Opportunities Fund BWG Edges Higher Holding Above Key Support
American Exceptionalism Acquisition Corp A AEXA Holds Near Resistance Amid Modest Decline
Larimar Therapeutics LRMR Holds Steady Near Support After Modest Gain